Neuron-specific enolase in hypertension patients with acute ischemic stroke and its value forecasting long-term functional outcomes

[1] Global Q(2017)Regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of Disease Study 2015 Lancet Neurol 16 877-97

[2] Ding R(2022)Global, Regional, and National Burden of ischemic stroke, 1990–2019 Neurology 98 e279-90

[3] Kaji S(2019)Global burden of neurological diseases highlights stroke Nat Rev Neurol 15 371-2

[4] Zaheer S(2013)Correlation between serum neuron specific enolase and functional neurological outcome in patients of acute ischemic stroke Ann Indian Acad Neurol 16 504-8

[5] Wiberg JJ(2017)Single versus serial measurements of neuron-specific enolase and prediction of poor neurological outcome in persistently unconscious patients after Out-Of-Hospital cardiac arrest - A TTM-Trial Substudy PLoS ONE 12 e0168894-25

[6] Egea-Guerrero HV(2014)[An experimental model of mass-type brain damage in the rat: expression of brain damage based on neurospecific enolase and protein S100B] Med Intensiva 38 218-8

[7] Singh DP(2013)Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit Clin Chim Acta 419 136-63

[8] Streitbürger A(2012)Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study PLoS ONE 7 e43284-49

[9] Gonzalez-Quevedo MJ(2016)Serum neuron specific enolase could predict subclinical brain damage and the subsequent occurrence of brain related vascular events during follow up in essential hypertension J Neurol Sci 363 158-56

[10] Cipolla DS(2018)The importance of comorbidities in ischemic stroke: impact of hypertension on the cerebral circulation J Cereb Blood Flow Metab 38 2129-24

[1] Global Q(2017)Regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of Disease Study 2015 Lancet Neurol 16 877-97

[2] Ding R(2022)Global, Regional, and National Burden of ischemic stroke, 1990–2019 Neurology 98 e279-90

[3] Kaji S(2019)Global burden of neurological diseases highlights stroke Nat Rev Neurol 15 371-2

[4] Zaheer S(2013)Correlation between serum neuron specific enolase and functional neurological outcome in patients of acute ischemic stroke Ann Indian Acad Neurol 16 504-8

[5] Wiberg JJ(2017)Single versus serial measurements of neuron-specific enolase and prediction of poor neurological outcome in persistently unconscious patients after Out-Of-Hospital cardiac arrest - A TTM-Trial Substudy PLoS ONE 12 e0168894-25

[6] Egea-Guerrero HV(2014)[An experimental model of mass-type brain damage in the rat: expression of brain damage based on neurospecific enolase and protein S100B] Med Intensiva 38 218-8

[7] Singh DP(2013)Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit Clin Chim Acta 419 136-63

[8] Streitbürger A(2012)Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study PLoS ONE 7 e43284-49

[9] Gonzalez-Quevedo MJ(2016)Serum neuron specific enolase could predict subclinical brain damage and the subsequent occurrence of brain related vascular events during follow up in essential hypertension J Neurol Sci 363 158-56

[10] Cipolla DS(2018)The importance of comorbidities in ischemic stroke: impact of hypertension on the cerebral circulation J Cereb Blood Flow Metab 38 2129-24